메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기
Quratis

We hope to become a company with a social impact that leads the human public health.

Press

  • HOME
  • Support
  • Press
No Subject Date Hit
21 [Blue Ocean CDMO] Samsung Biologics with 90 billion won in business profits, ranked third 2020.07.09 786
20 Quratis submitted a preliminary review as a technology special listed company 2020.06.19 797
19 Quratis, specialization in tuberculosis vaccine company 2020.06.18 829
18 Yu-Hwa Choi, Managing Director of Quratis, was awarded from the Korean Health Industry Devleopment I... 2020.05.29 1,058
17 Quratis 'A brilliant company 2019' and 'Bio Grand Award’ 2020.04.24 1,199
16 Minister’s Award (Technology Innovation), Ministry of SMEs and Startups (December 13 2019) 2020.02.13 1,043
15 [2019.06.25] A future K-Bio star.show off one's technical skills 2019.06.25 1,569
14 [2019.05.15] Greeting the construction of the Osong bio plant 2019.05.15 1,655
13 [2019.04.26] Quratis trying to enter KOSDAQ 2019.04.26 1,299
12 [2019.04.24] Quratis, a tuberculosis vaccine, pushed for IPO 2019.04.24 1,641
11 [2019.01.30] Quratis to Start Clinical Research on Youth Tuberculosis Vaccines 2019.01.30 888
10 [2019.01.15] Quratis, Added Clinical Approval for Young Tuberculosis Vaccine 2019.01.15 746
9 [2018.10.29] Quratis for Prohibition Vaccines Raises 20 Billion for 'GMP Implementation' 2018.10.29 937
8 [2018.09.26] Three medical ventures, including Quratis, move into Osong Cheombok Complex in Cheongju... 2018.09.26 703
7 Quratis starts 2a clinical trial of adult tuberculosis vaccine this January (Jan 08, 2018) 2018.01.08 604
6 [2018.01.04] Quratis Securing Vaccine Sovereignty 'Start-up' 2018.01.04 804
5 [2018.01.02] Quratis, First Approves for Phase 2a Clinical Trials of adults Tuberculosis Vaccine in ... 2018.01.02 774
4 [2017.09.22] [2017 Bio-health Investment Festival] Quratis 2017.09.22 735
3 [2017.09.08] Quratis and Adult Tuberculosis Vaccines 'advance' in localization 2017.09.08 693
2 [2017.08.31] Quratis, Development of Tuberculosis Vaccines for Adults 2017.08.31 1,046
<< < 1 2 > >>